----
Current ValuationThe current P/E ratio is 98.88, within the reasonable range, cheaper than 44.23% of the time in the past 1 years, and the industry ranks 55/255, the industry Median -1.26.
98.88xP/E
$36.31Stock price
$0.37Earnings per share
98.88xP/E
Stock price$36.31Earnings per share$0.37
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 69.85x
- Typical range
- 46.02x–180.94x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0295887116
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
PCRXUSPacira BioSciences | 98.88x | 302.08% | $1.45B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
